Hadox Research Labs · Science Intelligence
We watch the research landscape, compare papers with fair peers, read the full text and publish the receipts. No journal logo, citation count or model gets the last word alone.
Current truthThe ascendance engine is still building history. This edition is editorially selected, not algorithmically declared “rising.”
Comparison universe1,138 current candidates across 41 age, field and article-type cohorts.
Evidence gateEvery public dossier was read from an authorised full body. Abstract-only records remain ineligible.
As of25 Jul 2026
This public, sanitized index unites the observatory with Hadox's reviewed dossiers. Bibliographic metadata and measured signal states are visible; abstracts and source text are not.
Tracking is not endorsement. A row means Hadox is monitoring the paper or has completed a public dossier. Radar states appear only when measured against age-, field- and article-type peers; no metric is invented for editorial selections.
Read the selection method| Paper | Field | Radar state | Attention | Next review | Hadox |
|---|---|---|---|---|---|
| Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance Cell · 2026-06-01 · 10.1016/j.cell.2026.05.036 | Pulmonary and Respiratory Medicine Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 50% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Cysteine’s metabolic fork: Sulfur partitioning shapes T cell function Cell · 2026-06-01 · 10.1016/j.cell.2026.05.011 | Biochemistry, Genetics and Molecular Biology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 32% · 37 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| D-SPIN constructs regulatory network models from scRNA-seq that reveal organizing principles of perturbation response Cell · 2026-06-01 · 10.1016/j.cell.2026.04.028 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 32% · 25 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Deep-sea megafauna co-opts microbial energy metabolism genes to withstand ultra-long starvation Cell · 2026-06-01 · 10.1016/j.cell.2026.05.012 | Physical Sciences Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 78% · 38 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Department of Error The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01257-2 | Cardiology and Cardiovascular Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 50% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Department of Error The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01134-7 | Cardiology and Cardiovascular Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 50% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Department of Error The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01201-8 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 34% · 86 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Department of Error The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01200-6 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 34% · 86 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Differential inhibition of Morbillivirus and Henipavirus polymerases by ERDRP-0519 and structure-guided inhibitor optimization Cell · 2026-06-01 · 10.1016/j.cell.2026.04.011 | Epidemiology Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 75% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| DNA repair drives cisplatin-induced neuronal death Cell · 2026-06-01 · 10.1016/j.cell.2026.05.025 | Molecular Biology Research article | Baseline Candidate · 1 signal point | 1 citations Cohort 72% · 25 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)00691-4 | Medicine Research article | Baseline Candidate · 1 signal point | 3 citations Cohort 88% · 86 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Engineered commensals for metabolic modulation of the gut-liver-brain axis Cell · 2026-06-01 · 10.1016/j.cell.2026.03.048 | Medicine Research article | Baseline Candidate · 1 signal point | 4 citations Cohort 93% · 86 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Epidemiology of cardiometabolic multiple long-term conditions The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)00606-9 | Epidemiology Research article | Baseline Candidate · 1 signal point | 2 citations Cohort 75% · 6 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Ethical shunts: an old woman in an Italian emergency department The Lancet · 2026-06-01 · 10.1016/s0140-6736(26)01098-6 | Neuroscience Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 25% · 12 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
| Excessive epithelial mechanosensation drives nociceptive innervation and chronic bladder pain via the PIEZO1-SLC7A11-glutamate axis Cell · 2026-06-01 · 10.1016/j.cell.2026.05.049 | Medicine Research article | Baseline Candidate · 1 signal point | 0 citations Cohort 34% · 86 peers · signal 2026-07-21 | 2026-08-04 assessed 2026-07-21 | Tracking Not yet a public dossier |
These are the exact visual editions already shared by Hadox. Each one now has a canonical source, immutable assets and a visible workflow state; publication history never substitutes for scientific review.
01
The source is identified, but no authorised full body is available for Hadox review yet.
02
Published edition linked to a full-text Hadox evidence dossier.
03
This official-source story is awaiting the institutional evidence workflow.
Historical copy retained; correction logged in the workflow.
Today, 0 papers have enough history for a momentum score and 0 public dossiers were selected by an open ascendance gate. That is not a failure to hide; it is the calibration state.
current paper assessments from Crossref + Openalex
cohorts split by paper age, article type and discipline
baseline · 1 watch · 0 rising
01Observe attention against fair peers.
02Wait for enough history to measure velocity.
03Read the authorised full paper and map every claim.
04Make a separate editorial decision and publish the evidence.